The POM Monoclonals: A Set of Antibodies for Prion Protein Research
Author Information
Author(s): Polymenidou Magdalini, Moos Rita, Scott Mike, Sigurdson Christina, Shi Yong-zhong, Yajima Bill, Hafner-Bratkovič Iva, Jerala Roman, Hornemann Simone, Wuthrich Kurt, Bellon Anne, Vey Martin, Garen Graciela, James Michael N. G., Kav Nat, Aguzzi Adriano
Primary Institution: Institute of Neuropathology, University Hospital Zurich, Zurich, Switzerland
Hypothesis
The study aims to develop a comprehensive collection of monoclonal antibodies against various epitopes of the prion protein.
Conclusion
The POM collection of antibodies provides valuable tools for studying prion diseases and their associated proteins.
Supporting Evidence
- The antibodies were able to bind to various epitopes of the prion protein.
- Some antibodies recognized epitopes resilient to protease digestion.
- The POM collection allows for studies using techniques like western blotting and ELISA.
Takeaway
Scientists created special antibodies to help understand prion diseases better. These antibodies can stick to different parts of the prion protein.
Methodology
Monoclonal antibodies were developed by immunizing Prnpo/o mice with recombinant mouse prion protein and selecting for binding to various epitopes.
Limitations
The study may not cover all possible epitopes of the prion protein, and the antibodies may have varying effectiveness across different species.
Participant Demographics
Prnpo/o mice were used for antibody production.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website